Discovery of a Novel Triazolopyridine Derivative as a Tankyrase Inhibitor

More than 80% of colorectal cancer patients have adenomatous polyposis coli (APC) mutations, which induce abnormal WNT/β-catenin activation. Tankyrase (TNKS) mediates the release of active β-catenin, which occurs regardless of the ligand that translocates into the nucleus by AXIN degradation via the...

Descripción completa

Detalles Bibliográficos
Autores principales: Ryu, Hwani, Nam, Ky-Youb, Kim, Hyo Jeong, Song, Jie-Young, Hwang, Sang-Gu, Kim, Jae Sung, Kim, Joon, Ahn, Jiyeon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8303674/
https://www.ncbi.nlm.nih.gov/pubmed/34298950
http://dx.doi.org/10.3390/ijms22147330

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8303674/
https://www.ncbi.nlm.nih.gov/pubmed/34298950
http://dx.doi.org/10.3390/ijms22147330

Ejemplares similares